International Journal of Health Policy and Management - Articles List

Keywords = Food and Drug Administration (FDA)

Looking Beyond FDA Warning Letters to Explore Unforeseen Trouble Spots in eDTCA: A Response to Recent Commentaries

Volume 5, Issue 10, 2016, Pages 611-612

10.15171/ijhpm.2016.92

Hyosun Kim

The Conundrum of Online Prescription Drug Promotion; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”

Volume 5, Issue 6, 2016, Pages 391-392

10.15171/ijhpm.2016.33

Isaac Wanasika

Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”

Volume 5, Issue 4, 2016, Pages 271-274

10.15171/ijhpm.2016.11

Tim K. Mackey

Still the Great Debate – “Fair Balance” in Direct-to-Consumer Prescription Drug Advertising; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”

Volume 5, Issue 4, 2016, Pages 287-288

10.15171/ijhpm.2016.17

Brent L. Rollins

Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters

Volume 4, Issue 12, 2015, Pages 813-821

10.15171/ijhpm.2015.157

Hyosun Kim

International Journal of Health Policy and Management

Journal Archive

Volume 12 (2023)

Volume 11 (2022)

Volume 10 (2021)

Volume 9 (2020)

Volume 8 (2019)

Volume 7 (2018)

Volume 6 (2017)

Volume 5 (2016)

Volume 4 (2015)

Volume 3 (2014)

Volume 2 (2014)

Volume 1 (2013)